See more : PT Citatah Tbk (CTTH.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Venus Remedies Limited (VENUSREM.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Venus Remedies Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Deutsche Wohnen SE (DWHHF) Income Statement Analysis – Financial Results
- Premier Fishing & Brands Limited (PFB.JO) Income Statement Analysis – Financial Results
- SES AI Corporation (SES) Income Statement Analysis – Financial Results
- Advance International Company for Communication and Information Technology (9524.SR) Income Statement Analysis – Financial Results
- Gerdau S.A. (GGBR3.SA) Income Statement Analysis – Financial Results
Venus Remedies Limited (VENUSREM.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.venusremedies.com
About Venus Remedies Limited
Venus Remedies Limited engages in the development and marketing of pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizers, hormones, iron supplements, neurology, oncology, pain management, respiratory, skin care, wound management, stress reliever, urology, and vitamins/minerals/nutrients, as well as antimicrobial resistance products. It is also involved in the provision of anti-infective, anticoagulant, and a portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.91B | 5.53B | 5.99B | 5.48B | 3.39B | 3.17B | 3.69B | 3.96B | 4.15B | 4.63B | 5.36B | 4.68B | 4.09B | 3.63B | 3.15B | 2.70B | 2.18B | 1.46B |
| Cost of Revenue | 3.73B | 3.45B | 4.00B | 3.52B | 1.85B | 1.92B | 2.14B | 2.36B | 2.47B | 2.77B | 3.08B | 2.69B | 2.32B | 2.01B | 1.93B | 1.69B | 1.38B | 932.74M |
| Gross Profit | 2.18B | 2.08B | 1.99B | 1.96B | 1.54B | 1.25B | 1.56B | 1.60B | 1.68B | 1.86B | 2.28B | 1.99B | 1.77B | 1.62B | 1.22B | 1.00B | 803.46M | 532.07M |
| Gross Profit Ratio | 36.90% | 37.59% | 33.22% | 35.79% | 45.51% | 39.38% | 42.09% | 40.33% | 40.52% | 40.21% | 42.57% | 42.47% | 43.29% | 44.51% | 38.80% | 37.28% | 36.80% | 36.32% |
| Research & Development | 158.40M | 228.85M | 230.30M | 157.58M | 100.84M | 146.53M | 306.39M | 363.94M | 107.00M | 120.83M | 166.57M | 160.26M | 141.59M | 128.35M | 110.78M | 77.41M | 51.55M | 30.72M |
| General & Administrative | 127.69M | 115.55M | 84.13M | 111.64M | 104.64M | 56.73M | 71.76M | 44.01M | 32.59M | 41.12M | 32.86M | 24.65M | 29.29M | 511.27M | 100.93M | 105.92M | 78.88M | 65.32M |
| Selling & Marketing | 658.07M | 523.30M | 489.51M | 660.29M | 396.32M | 314.07M | 386.81M | 325.12M | 394.70M | 440.09M | 395.49M | 289.38M | 284.59M | 342.75M | 267.11M | 185.00M | 127.26M | 66.82M |
| SG&A | 785.76M | 638.85M | 573.64M | 771.93M | 500.97M | 370.79M | 458.56M | 369.13M | 427.29M | 481.20M | 428.36M | 314.03M | 313.89M | 511.27M | 368.05M | 290.92M | 206.13M | 132.14M |
| Other Expenses | 1.24B | 10.99M | 10.78M | 130.13M | 23.73M | 22.62M | 20.06M | 18.45M | 15.27M | 2.24M | 923.00K | 1.70M | 2.65M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.18B | 1.80B | 1.70B | 1.78B | 1.46B | 1.26B | 1.50B | 1.49B | 1.29B | 1.43B | 1.33B | 1.12B | 988.06M | 900.96M | 616.24M | 434.65M | 322.44M | 203.46M |
| Cost & Expenses | 5.91B | 5.25B | 5.70B | 5.30B | 3.31B | 3.19B | 3.64B | 3.86B | 3.75B | 4.20B | 4.41B | 3.81B | 3.31B | 2.92B | 2.54B | 2.13B | 1.70B | 1.14B |
| Interest Income | 41.66M | 18.99M | 8.16M | 1.22M | 71.91M | 2.90M | 2.49M | 2.41M | 3.76M | 2.61M | 2.46M | 1.58M | 1.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 937.00K | 1.18M | 1.98M | 70.10M | 116.63M | 221.15M | 338.25M | 340.73M | 326.20M | 315.56M | 250.08M | 216.29M | 245.54M | 188.64M | 140.70M | 93.55M | 47.68M | 28.09M |
| Depreciation & Amortization | 264.43M | 322.98M | 335.34M | 352.76M | 320.12M | 339.80M | 338.33M | 402.57M | 415.75M | 459.97M | 402.17M | 330.76M | 112.70M | 191.00M | 137.41M | 66.33M | 64.76M | 40.61M |
| EBITDA | 711.80M | 605.10M | 625.77M | 545.57M | 373.14M | 296.59M | 397.71M | 529.91M | 778.09M | 894.78M | 1.38B | 1.21B | 1.00B | 905.97M | 741.90M | 636.64M | 545.78M | 369.21M |
| EBITDA Ratio | 12.03% | 12.71% | 11.72% | 12.30% | 15.12% | 11.13% | 10.86% | 13.30% | 18.75% | 17.30% | 25.04% | 25.12% | 24.61% | 24.95% | 23.58% | 23.62% | 25.00% | 25.21% |
| Operating Income | 331.57M | 273.20M | 280.97M | 108.79M | 39.75M | -148.92M | 56.40M | 42.05M | 35.07M | 26.48M | 690.79M | 628.36M | 551.51M | 714.97M | 604.49M | 570.31M | 481.02M | 328.61M |
| Operating Income Ratio | 5.61% | 4.94% | 4.69% | 1.98% | 1.17% | -4.69% | 1.53% | 1.06% | 0.85% | 0.57% | 12.88% | 13.43% | 13.49% | 19.69% | 19.21% | 21.16% | 22.03% | 22.43% |
| Total Other Income/Expenses | 114.86M | -220.94M | -257.06M | -52.24M | -168.42M | -282.71M | -331.72M | -258.43M | -326.44M | -400.04M | -236.99M | -244.19M | -259.88M | -188.64M | -140.70M | -93.55M | -47.68M | -28.09M |
| Income Before Tax | 446.43M | 379.30M | 364.08M | 485.53M | -80.36M | -297.26M | -275.32M | -216.38M | 35.07M | 26.48M | 690.79M | 628.36M | 508.52M | 526.33M | 463.78M | 476.77M | 433.34M | 300.52M |
| Income Before Tax Ratio | 7.55% | 6.85% | 6.08% | 8.86% | -2.37% | -9.36% | -7.45% | -5.46% | 0.85% | 0.57% | 12.88% | 13.43% | 12.44% | 14.50% | 14.74% | 17.69% | 19.85% | 20.52% |
| Income Tax Expense | 161.53M | 113.65M | -43.16M | -132.12M | 19.64M | -11.51M | 31.60M | -45.57M | 18.08M | -25.13M | 47.82M | 55.27M | 37.75M | 64.15M | 68.20M | 37.25M | 75.24M | 46.68M |
| Net Income | 284.91M | 265.70M | 407.24M | 617.65M | -99.99M | -285.75M | -306.92M | -170.81M | 16.99M | 51.61M | 642.97M | 573.09M | 470.77M | 462.18M | 395.59M | 439.52M | 358.10M | 253.84M |
| Net Income Ratio | 4.82% | 4.80% | 6.80% | 11.27% | -2.95% | -9.00% | -8.31% | -4.31% | 0.41% | 1.11% | 11.99% | 12.25% | 11.52% | 12.73% | 12.57% | 16.31% | 16.40% | 17.33% |
| EPS | 21.31 | 19.87 | 30.47 | 50.04 | -8.10 | -23.16 | -24.87 | -14.88 | 1.48 | 4.51 | 57.17 | 58.80 | 51.22 | 50.63 | 46.69 | 51.99 | 42.36 | 30.19 |
| EPS Diluted | 21.31 | 19.87 | 30.47 | 50.04 | -8.10 | -23.16 | -24.87 | -14.88 | 1.48 | 4.51 | 57.17 | 58.80 | 51.22 | 50.63 | 46.69 | 51.99 | 42.36 | 30.19 |
| Weighted Avg Shares Out | 13.37M | 13.37M | 13.37M | 12.34M | 12.34M | 12.34M | 12.34M | 11.48M | 11.44M | 11.44M | 11.25M | 9.75M | 9.19M | 9.13M | 8.47M | 8.45M | 8.45M | 8.41M |
| Weighted Avg Shares Out (Dil) | 13.37M | 13.37M | 13.37M | 12.34M | 12.34M | 12.34M | 12.34M | 11.48M | 11.48M | 11.44M | 11.25M | 9.75M | 9.19M | 9.13M | 8.47M | 8.45M | 8.45M | 8.41M |
Source: https://incomestatements.info
Category: Stock Reports